Antimicrobial susceptibility profile, treatment outcome and serotype distribution of clinical isolates of Salmonella enterica subspecies enterica: a 2-year study from Kerala, South India

Figures & data

Table 1 Isolation of Salmonella enterica subspecies enterica serotypes

Organisms	Number (N=118)	%
Salmonella Typhi	79	66.95
Salmonella Paratyphi A	22	18.64
Salmonella Typhimurium	12	10.17
Salmonella species	5	4.23

Table 2 Salmonella enterica serotype distribution in clinical samples (N=118)

Clinical sample	Number of isolates	Salmonella Typhi	Salmonella Paratyphi A	Salmonella Typhimurium	Salmonella spp.
Blood	112	78	22	8	4
Stool	4	0	0	4	0
Urine	1	1	0	0	0
Synovial fluid	1	0	0	0	1

Table 3 Percentage susceptibility of Salmonella enterica isolates (August 2011–July 2013)

Isolates	Number of isolates	Salmonella Typhi		Salmonella Paratyphi A		Salmonella spp.		Salmonella Typhimurium
		N=79		N=22		N=5		N=12
		n	%	n	%	n	%	n	%
Cotrimoxazole 25 μg		60	75.94	21	95.45	5	100	12	100
Ampicillin 10 μg		61	77.21	22	100	5	100	12	100
Ciprofloxacin 5 μg		26	32.91	9	40.90	5	100	8	66.66
Nalidixic acid 30 μg		10	12.65	0	0	5	100	7	58.33
Ceftriaxone 30 μg		79	100	22	100	5	100	12	100
Chloramphenicol 30 μg		75	94.93	20	90.90	5	100	12	100
Ofloxacin 5 μg		52	65.82	18	81.81	5	100	12	100
Azithromycin 15 μg		62	78.48	21	95.45	4	80	12	100